A Phase I Trial of Ribavirin and Low-Dose Cytarabine for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia With Elevated eIF4E
Haematologica- Italy
doi 10.3324/haematol.2014.111245
Full Text
Abstract
Available in
Categories
Date
November 25, 2014
Authors
Publisher
Ferrata Storti Foundation (Haematologica)